Loading…
Loading…
SLRX (Salarius Pharmaceuticals, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
| INDP | Indaptus Therapeutics, Inc. | $1.16 | $131.4M |
| GTBP | GT Biopharma, Inc. | $0.30 | $9.5M |
| REVB | Revelation Biosciences, Inc. | $1.03 | $4.0M |
| ATXI | Avenue Therapeutics, Inc. | $0.58 | $1.9M |
| ENVB | Enveric Biosciences, Inc. | $1.37 | $817.9K |
| SPRC | SciSparc Ltd. | $6.62 | $382.9K |
| NKGN | NKGen Biotech, Inc. | $0.00 | $274.3K |
| SLXN | Silexion Therapeutics Ltd. | $0.36 | $150.9K |
| PBM | Psyence Biomedical Ltd. | $4.31 | $82.0K |
| LIPO | Lipella Pharmaceuticals Inc. | $0.00 | $1.8K |